Voriconazole Plasma Concentrations in Immunocompromised Pediatric Patients Vary by <i>CYP2C19</i> DiplotypesJ. Kevin Hicks, Mary V. Relling, Calvin C. Daniels et al.|Pharmacogenomics|2014Cited by 68
Optimizing Drug-Drug Interaction Alerts Using a Multidimensional ApproachCalvin C. Daniels, James M. Hoffman, Jonathan D. Burlison et al.|PEDIATRICS|2019Cited by 21